Henry H. Du
VP of Finance & Accounting and Interim CFOMr. Henry H. Du, CPA is Director of Emmaus Life Sciences, Inc. from April 16, 2026. He is Interim Chief Financial Officer and Vice President of Finance and Accounting at Alpha Cognition Inc. from October 21, 2024. Mr. Du joined the Alpha Cognition Inc. in October 2024. Mr. Du served as Senior Vice President of Accounting & Administration of Amplify Surgical Inc since 2024 until October 2024 and served as its Chief Financial Officer. Prior to joining Amplify Surgical, he was VP of Finance and Senior Corporate Controller at HUYABIO International, the leader in globalizing Chinese pharmaceutical innovation, where he established the commercial accounting policy for the company’s product launch in Japan. Mr. Du also previously served as Corporate Controller at Eledon Pharmaceuticals (formerly Novus Therapeutics), a publicly traded clinical-stage biopharmaceutical company, where he led the accounting operations and SEC reporting functions. Additionally, he was Controller at United Auto Credit and spent numerous years at Avanir Pharmaceuticals, Pacifc Life Insurance Company, The Siegfried Group and Cardiogenesis Corporation in various leadership positions of increasing responsibility. Mr. Du started his career in public accounting at the Big 4 accounting frm of PricewaterhouseCoopers. He earned his B.A. in Economics-Accounting from Claremont McKenna College. He is a licensed Certifed Public Accountant (CPA) in the State of California.
Positions
- Company NameAlpha Cognition Inc.Stock CodeACOGPositionVP of Finance & Accounting and Interim CFOColleagues
- MEMichael E. McFaddenCEO & Director
- RJRobert James WillsIndependent Chairman of the Board
- KAKenneth Anthony CawkellFounder, Consultant, Corporate Secretary & Director
- LDLauren D’AngeloChief Operating Officer
- DGDenis G. KayChief Scientific Officer
- PMPhillip MertzIndependent Director
- RKRajeev K. BakshiIndependent Director
